Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose
US9758553B2 · kind B2 · utility
0Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2014 |
| Grant date | Sep 12, 2017 |
| Priority date | — |
| Expiry date | Jul 2, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12P21/005
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Lower eukaryotic host cells have been engineered to produce glycoprotein having at least one terminal α-galactosyl epitope. The glycoproteins are useful for the production of highly antigenic glycoprotein compositions with advantages for the production of vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.